Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Tenofovir Alafenamide for HBV Prophylaxis in Post Orthotopic Liver Transplant [Phase 4]
Phase 4 clinical trial update evaluating tenofovir alafenamide for HBV prophylaxis after liver transplantation.
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients [Phase 4]
Phase 4 clinical trial update evaluating an optimal antiviral treatment in HBeAg-positive chronic hepatitis B patients; status currently unk…
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity [Phase 3]
A Phase 3 clinical trial evaluating ribavirin to enhance hepatitis B nucleotide analogue antiviral activity is ongoing, with chronic hepatit…
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013) [Phase 3]
Phase 3 clinical trial update evaluating a Hepatitis B vaccine challenge after prior Vaxelis vaccination has completed; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO) [Phase 2, Phase 3]
A phase 2/3 clinical trial update on direct-acting antivirals (DAAs) for patients with chronic hepatitis C infection and HBV coinfection; st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-26Clinical Trial Update: A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B [Phase 2]
Phase 2 clinical trial investigating APG-1387 in combination with Entecavir for chronic hepatitis B is ongoing with status not disclosed.
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection [Phase 2]
A Phase 2 clinical trial evaluating Ledipasvir/Sofosbuvir for Hepatitis B has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG) [Phase 3]
Phase 3 trial for an hepatitis B virus antibody booster program intended for production of Hepatitis B immune globulin (HBIG) was terminated…
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: The Efficacy of Prophylactic TAF for HBsAg-positive Patients Receiving bDMARDs [Phase 4]
Clinical trial update reporting on prophylactic TAF for HBsAg-positive patients receiving biological DMARDs in inflammatory arthritis (Phase…
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China [Phase 4]
Phase 4 trial evaluating a 12-week SOF/VEL regimen with prophylactic TAF in treatment-naïve genotype 1-6 HCV/HBV coinfected adults, with or …
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients [Phase 4]
Phase 4 trial evaluating the efficacy and safety of TenofoBell tablet in chronic hepatitis B has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine [Phase 4]
Phase 4 trial update comparing immunization schedules of inactivated Hepatitis A vaccine with a combined Hepatitis A and B vaccine; study co…
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines [Phase 4]
Phase 4 clinical trial update on a vaccination adjuvant for Hepatitis B in healthcare workers who did not respond to standard vaccines; resu…
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Hepatitis B Birth Dose for Newborns [Phase 4]
A Phase 4 clinical trial update on administering a Hepatitis B birth dose to newborns has been completed.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients [Phase 4]
Phase 4 trial assessing the impact of entecavir on regression and outcomes in patients with HBV-related liver fibrosis and cirrhosis.
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B [Phase 4]
Phase 4 clinical trial evaluating Tenofovir Alafenamide to prevent mother-to-child transmission of Hepatitis B.
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis [Phase 2, Phase 3]
A randomized placebo-controlled trial evaluating safety and efficacy of silymarin in acute viral hepatitis was terminated after Phase 2/3.
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Efficacy and Safety of DA-2802 in Chronic Hepatitis B Patients [Phase 3]
Phase 3 trial update on DA-2802 shows efficacy and safety in chronic hepatitis B patients.
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection [Phase 1]
Phase 1 study of RO7239958 in healthy volunteers and Hepatitis B patients was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001 [Phase 2]
Phase 2 study evaluating induction of hepatitis B virus neutralizing antibodies with VVX001 is in progress with status not yet determined.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient [Phase 1, Phase 2]
Phase 1/2 clinical trial of recombinant human serum albumin/interferon alpha2b fusion protein for Hepatitis B has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-29Clinical Trial Update: Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir. [Phase 4]
Phase 4 trial evaluating switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) versus maintaining TDF in chronic…
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand [Phase 3]
Phase 3 trial evaluating maternal antiviral prophylaxis to prevent perinatal transmission of hepatitis B in pregnant women in Thailand; stud…
-
FDA approval · 2021-03-04FDA Approved: VEMLIDY — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Vemlidy (tenofovir alafenamide) filed by Gilead Sciences.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC [Phase 4]
Phase 4 clinical trial evaluating the immunogenicity of a birth dose of the hepatitis B vaccine conducted in the Democratic Republic of the …